As of April 29, 2025, FibroBiologics (FBLG) has a market cap of $39.793 million USD. According to our data, FibroBiologics is ranked No.8248 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $39.79 M |
-45.35%
|
Dec 31, 2024 | $72.82 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vericel
VCEL
|
$1.97 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.47 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
Market Cap | = | FBLG Stock Price | * | FBLG Shares Outstanding |
= | $1.04 | * | 38.26 M | |
= | $39.79 M |